Email

Glucocorticoid-Induced Osteoporosis Guideline

Logo

Guideline Status

Step 8: Guideline summary posted


Step 9: Peer review by journal


See a list of all clinical practice guideline project steps on the Clinical Practice Guidelines page. 


2022 GIOP Guideline

2022 ACR Guideline for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis Guideline Summary

Updated July 9, 2023

2022 ACR Guideline for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis (GIOP) (final publication anticipated summer 2023)


2017 GIOP Guideline

2017 ACR Guideline for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis

Documents related to the 2017 guideline:

Appendix 1 – Methods 2017

Appendix 2 – Panel/Teams Involved 2017

Appendix 3 – Evidence Report 2017

Appendix 4 – Search Strategies 2017

Appendix 5 – Study Selection Process 2017

Disclosure Summary 2017

Project Plan 2017

Public Comments 2017

Response to Public Comments 2017


2010 GIOP Guideline

ACR 2010 Recommendations for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis

Document related to the 2010 guideline:

ACR 2010 Recommendations for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis – Clinician’s Guide

Endorsed by the American Society for Bone and Mineral Research

We use cookies on our website to improve our service to you and for security purposes. By continuing to use our site without changing your browser cookie settings, you agree to our cookie policy and the use of cookies. See ACR Policies